These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8697618)

  • 1. Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors.
    Aaberge IS; Steinsvik TE; Groeng EC; Leikvold RB; Løvik M
    Clin Exp Immunol; 1996 Jul; 105(1):12-7. PubMed ID: 8697618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection.
    Aaberge IS; Michaelsen TE; Rolstad AK; Groeng EC; Solberg P; Løvik M
    Infect Immun; 1992 Oct; 60(10):4146-53. PubMed ID: 1398925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes.
    Steinsvik TE; Gaarder PI; Aaberge IS; Løvik
    Scand J Immunol; 1995 Dec; 42(6):607-16. PubMed ID: 8552984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total and birch pollen-specific human IgE in mice with severe combined immunodeficiency transplanted with human peripheral blood lymphocytes: donor dependence, seasonal variation and in vivo half-life.
    Steinsvik TE; Aaberge IS; Gaarder PI; Bjønness U; Løvik M
    Int Arch Allergy Immunol; 1997 Feb; 112(2):175-83. PubMed ID: 9030099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced human antibody responses to the Haemophilus influenzae b polysaccharide in severe combined immunodeficient mice engrafted with human leukocytes.
    Lucas AH; Siff TE; Trujillo KH; Kitamura MY
    Pediatr Res; 1992 Jul; 32(1):132-5. PubMed ID: 1635839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
    Nonoyama S; Smith FO; Ochs HD
    J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
    Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
    J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tetanus toxoid antibody production and protection against lethal doses of tetanus toxin in hu-PBL-SCID mice.
    Naito S; Okada Y; Takahashi M; Kato H; Taneichi M; Ami Y; Suzaki Y; Oka T; Okuma K; Morokuma K; Onodera H; Inoue M; Takahashi Y; Yamazaki S; Kimura H; Komuro K; Uchida T
    Int Arch Allergy Immunol; 2000 Oct; 123(2):149-54. PubMed ID: 11060487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary human immune response to Neisseria meningitidis serogroup C in interleukin-12-treated severe combined immunodeficient mice engrafted with human peripheral blood lymphocytes.
    Westerink MA; Metzger DW; Hutchins WA; Adkins AR; Holder PF; Pais LB; Gheesling LL; Carlone GM
    J Infect Dis; 1997 Jan; 175(1):84-90. PubMed ID: 8985200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice.
    Spiegelberg HL; Beck L; Kocher HP; Fanslow WC; Lucas AH
    J Clin Invest; 1994 Feb; 93(2):711-7. PubMed ID: 8113405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hu-PBL-SCID mouse model. Long-term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice.
    Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
    Cell Immunol; 1992 Feb; 139(2):468-77. PubMed ID: 1733515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human peripheral blood leukocyte-reconstituted severe combined immunodeficient mouse: analysis of the human immune response against porcine islet transplantation.
    Shiroki R; Naziruddin B; Shishido S; Duffy BF; Howard T; Mohanakumar T
    Transplantation; 1997 Mar; 63(6):818-23. PubMed ID: 9089220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.
    Lue C; Kiyono H; Fujihashi K; McGhee JR; Mestecky J
    Reg Immunol; 1992; 4(2):86-90. PubMed ID: 1503891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human IgE response in hu-PBL-SCID mice.
    Kilchherr E; Mandak V; Wagner K; Heusser CH
    Cell Immunol; 1993 Oct; 151(2):241-56. PubMed ID: 8402934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
    Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a cervical cancer model via inoculating SiHa Cells into humanized severe combined immunodeficient mice.
    Ye F; Chen H; Liang Z; Lu W; Cheng Q; Xie X
    Eur J Gynaecol Oncol; 2006; 27(6):566-72. PubMed ID: 17290584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation.
    Tissot JD; Schneider P; Schapira M; Duchosal MA
    Cell Immunol; 1996 Feb; 167(2):241-8. PubMed ID: 8603433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo production of specific human antibodies by vaccination of human-PBL-SCID mice.
    Walker W; Gallagher G
    Immunology; 1994 Oct; 83(2):163-70. PubMed ID: 7530687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.